IFNG and COVID-19: identified six cytokines (IFN-β, IFN-λ1, IFN-γ, CXCl9, CXCL10, IL-8, sTIM-3) that were elevated in the COVID19+ PCC+ and PCC- versus controls at four months after COVID-19 infection, pointing to an immune signature specific to COVID-19 (14).